Fifty-six people with Charcot-Marie-Tooth disease completed an online questionnaire to express the benefits they felt from using medical cannabis:
- Most reported an improvement in pain of at least 50%,
- It led to a reduction in the use of opiate painkillers (for 80% of respondents), sleeping pills (for 68%) and medication for anxiety or depression (for 50%).
Noting the diversity of forms of consumption and possible doses, the authors conclude that clinical studies are needed to enable therapeutic cannabis to be prescribed appropriately for CMT.
